Supplementary Table S2 from miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer
Sajni Josson(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System), Yi‐Tsung Lu(Samueli Institute), Jake Lichterman(Samueli Institute), Dhruv Sareen(Cedars-Sinai Medical Center), Ladan Fazli, Edwin M. Posadas(Cedars-Sinai Medical Center), Dror Berel(Baylor College of Medicine), Srinivas Nandana(Samueli Institute), Murali Gururajan(Pfizer (United States)), André Rogatko(Cedars-Sinai Medical Center), Chunyan Liu(Central South University), Chen Shao(Anhui Medical University), Quanlin Li(Cedars-Sinai Medical Center), Peizhen Hu(Xijing Hospital), Gina Chia‐Yi Chu(Multimeric Biotherapeutics (United States)), Haiyen E. Zhau(Cedars-Sinai Medical Center), Kaiqin Lao(Life Systems (United States)), Chia-Lun Lu(Samueli Institute)
Cited by 0
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520